EpiVax, Inc. - Informatics and Immunology
  • Our Company
    • Company Overview
    • Corporate Responsibility
    • Mission, Vision & Values
    • Team
    • Careers
    • Contact Us
  • Pipeline
    • Pipeline Overview
    • EPV-CoV19: HCW Vaccine
    • BioDefense Vaccines
    • Tregitope: Immunomodulation Power Tool
    • Deimmunization Projects
  • Vaccine Services
    • Vaccine Services
    • COVID-19 Coverage
  • Immunogenicity Assessment
    • Immunogenicity Assessment Overview
    • ISPRI Web-based Immunogenicity Assessment
    • PreDeFT Analysis
    • JanusMatrix Analysis
    • High Throughput Antibody Immunogenicity Analysis
    • PANDA Screening
    • ISPRI for Host Cell Proteins
    • iVAX: Web-based Vaccine Design
    • PreVAX Analysis
  • Deimmunization
  • Lab Services
    • Lab Services Overview
    • T Cell Assays
    • HLA Binding Assays
    • HLA Transgenic Mice
    • In Vitro Immunization Protocol (IVIP)
  • Press Room
    • Press Room
    • Events
      • Webinars
    • Publication & Poster Search
    • Client Testimonials
    • Thinking Out Loud (Blog)
  • Contact Us
Select Page
FDA Webinar: Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling

FDA Webinar: Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling

by Riley Nolan | Jan 26, 2021 | Events, Featured, Webinars

The FDA hosted a virtual workshop January 26, 2021 to provide updates and foster discussions around non-clinical assays for comparative immunogenicity risk assessment of generic peptide products. Full Agenda Here. EpiVax CEO/CSO, Annie De Groot, presented an update on...
Antibody Industrial Symposium (AIS) 2020 Virtual

Antibody Industrial Symposium (AIS) 2020 Virtual

by Danielle Medeiros | Nov 16, 2020 | Events

Dr. Anne De Groot will be participating in the 8th annual AIS “Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases” Dr. De Groot will be speaking on Tuesday Nov 24, during the Track From Preclinical to Drug Approval at...
American Association of Pharmaceutical Scientists (AAPS) – PharmSci360

American Association of Pharmaceutical Scientists (AAPS) – PharmSci360

by Danielle Medeiros | Oct 27, 2020 | Events, Featured

EpiVax is proud to have three of our Director and Senior level scientists representing our work at the 2020 AAPS PharmSci 360 Meetings. There are several opportunities to catch up with them over the next two weeks including the following rapid fire talks: Brian...
PANDA: Immunogenicity of Peptide Drugs Webinar with Live Q&A

PANDA: Immunogenicity of Peptide Drugs Webinar with Live Q&A

by Danielle Medeiros | Sep 23, 2020 | Events, Webinars

Catch the replay We’re sorry, but this live event has passed.  You may watch the replay here. The video is hosted by Dropbox, in which case you will need to either be logged in to an account, or downlow the video in order to view the full recording.  Should you...
TIDES: Oligonucleotide and Peptide Therapeutics Virtual

TIDES: Oligonucleotide and Peptide Therapeutics Virtual

by Danielle Medeiros | Sep 23, 2020 | Events, Featured

EpiVax continues to “meet” with global clients despite pandemic restrictions through virtual meetings and conferences such as TIDES: Oligonucleotide and Peptide Therapeutics Virtual! In addition to participating in a Live Panel Discussion on FDA Draft...
Recorded: EpiVax EPV-CoV-19 Vaccine Webinar

Recorded: EpiVax EPV-CoV-19 Vaccine Webinar

by Danielle Medeiros | Sep 21, 2020 | Events, Webinars

Thank you for your continued interest in the status of our EpiVax’s EPV-CoV-19 Vaccine Program. This event has passed! But do not fear, there is a recording of the session available for access. Kindly fill out the information form linked below and an email...
« Older Entries

Recent Posts

  • FDA Webinar: Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling
  • January Newsletter: Duality Over Division
  • EpiVax and EpiVax Therapeutics Advance COVID-19 Vaccine Program, EPV-CoV-19
  • EpiVax Advances “PANDA” Peptide Therapeutic Immunogenicity Screening Program
  • December Newsletter: 2020 Hindsight! and Paying it Forward

Categories

  • EpiVax Immunoncology
  • Events
  • Featured
  • News
  • Thinking Out Loud -Blog
  • Webinars

Discover

  • Vaccine Services
  • Immunogenicity Assessment
  • Deimmunization
  • Lab Services
  • Pipeline

About

  • Our Company
  • Press Room
  • Events
  • Publication & Poster Search
  • Thinking Out Loud (Blog)
  • Contact Us

Connect

© 2021 EpiVax, Inc. – Informatics and Immunology, All rights reserved. • 188 Valley Street, Suite 424, Providence, RI 02909 • ph: 401.272.2123 • fax: 401.272.7562